Showing 481 - 500 results of 1,139 for search '"preclinical"', query time: 0.05s Refine Results
  1. 481
  2. 482
  3. 483

    Enhancing immunotherapy through PD‐L1 upregulation: the promising combination of anti‐PD‐L1 plus mTOR inhibitors by Anna Hernández‐Prat, Alejo Rodriguez‐Vida, Laura Cardona, Mengjuan Qin, Oriol Arpí‐Llucià, Luis Soria‐Jiménez, Sílvia Menendez, Fabricio Gerel Quimis, Miguel Galindo, Edurne Arriola, Marta Salido, Nuria Juanpere‐Rodero, Federico Rojo, Aura Muntasell, Joan Albanell, Ana Rovira, Joaquim Bellmunt

    Published 2025-01-01
    “…Increased expression of PD‐L1 under TAK‐228 exposure was confirmed in patient‐derived explants (PDEs) treated ex vivo. These preclinical findings suggest that mTOR inhibition with TAK‐228 can increase PD‐L1 levels, potentially impacting the specific immune response against UC cells. …”
    Get full text
    Article
  4. 484
  5. 485
  6. 486

    Development and characterization of orthotopic patient-derived xenograft models of peritoneal metastatic mucinous appendiceal adenocarcinoma by I. Ito, V.K. Pattalachinti, A.M.G. Yousef, S. Chowdhury, M.M. Fanaeian, E. Haque, B.B. Gunes, M. Yousef, E.R. Salle, M.A. Zeineddine, S. Ji, R. Li, W. Wang, B.A. Helmink, M.W. Taggart, M.G. White, K.F. Fournier, N.W. Fowlkes, J.P. Shen

    Published 2025-03-01
    “…Background: Appendiceal adenocarcinomas (AAs) are a rare and heterogeneous group of tumors for which few preclinical models exist. The lack of preclinical models of AA has hindered drug development and is a major factor in why AA remains without a single Food and Drug Administration-approved systemic treatment. …”
    Get full text
    Article
  7. 487
  8. 488

    The Role and the Regulation of NLRP3 Inflammasome in Irritable Bowel Syndrome: A Narrative Review by Arezina Kasti, Konstantinos Katsas, Maroulla D. Nikolaki, Konstantinos Triantafyllou

    Published 2025-01-01
    “…NLRP3 inflammasome is part of the nucleotide-binding oligomerization domain-like receptor (NLR) family, a crucial component of the innate immune system. Preclinical studies have demonstrated that inhibiting NLRP3 reduces visceral sensitivity and IBS symptoms, like abdominal pain, and diarrhea, suggesting that targeting the NLRP3 might represent a novel therapeutic approach for IBS. …”
    Get full text
    Article
  9. 489

    Targeting heparan sulfate proteoglycans as an effective strategy for inhibiting cancer cell migration and invasiveness compared to heparin by Lorenzo Depau, Jlenia Brunetti, Chiara Falciani, Elisabetta Mandarini, Marta Zanchi, Maria Francesca Paolocci, Marta Garfì, Alessandro Pini, Luisa Bracci

    Published 2025-01-01
    “…Despite a strong conceptual basis and promising preclinical results, clinical trials have failed to demonstrate any significant advantage of administering heparin to oncology patients. …”
    Get full text
    Article
  10. 490

    Natural Products for Cancer Therapy: A Review of Their Mechanism of Actions and Toxicity in the Past Decade by Yasir Osman Ali Abdalla, Bavani Subramaniam, Shaik Nyamathulla, Noorasyikin Shamsuddin, Norhafiza M. Arshad, Kein Seong Mun, Khalijah Awang, Noor Hasima Nagoor

    Published 2022-01-01
    “…This review can provide valuable insights for researchers in developing methods, strategies during preclinical and clinical evaluation of anticancer candidates.…”
    Get full text
    Article
  11. 491

    Herbal and tuberculosis in Indonesia: Bibliometric analysis by Nur Azizah Annisa, Stefani Widodo, Putri Damayanti Irma, Pratiwi Wardani Dita, Abidah Safithri, Muhammad Almanfaluthi

    Published 2025-01-01
    “…Keyword co-occurrence analysis identified “mycobacterium tuberculosis,” “animal experiment,” and “plant extract” as central themes, highlighting a predominant focus on preclinical research and the chemical analysis of plant-based treatments.…”
    Get full text
    Article
  12. 492

    Maternal Vitamin B12 in Pregnancy and Placental Development by Amrita Arcot, Rachel E. Walker, Kelly Gallagher, Kevin C. Klatt, Alison D. Gernand

    Published 2024-01-01
    “…Our literature search included preclinical model systems and human cohorts and interventions. …”
    Get full text
    Article
  13. 493
  14. 494

    A potential innovative surrogate marker for hypoxic injury: Shehata marker of angiogenesis by Shehata A. Mohamed

    Published 2025-01-01
    “…Methods: The adopted approach is a mix of preclinical testing and narration of published examples of individual correlations of the marker components. …”
    Get full text
    Article
  15. 495

    Effects of (±) 3,4-Methylenedioxymethamphetamine (MDMA) on Sleep and Circadian Rhythms by Una D. McCann, George A. Ricaurte

    Published 2007-01-01
    “…This paper will review preclinical and clinical studies that have explored the effects of prior MDMA exposure on sleep, circadian activity, and the circadian pacemaker, and will highlight current gaps in knowledge and suggest areas for future research.…”
    Get full text
    Article
  16. 496

    A critical review on phytochemical profile and health promoting effects of mung bean (Vigna radiata) by Kumar Ganesan, Baojun Xu

    Published 2018-03-01
    “…The various curative potential of mung bean provides successive preclinical outcomes in the field of drug discovery and this review strongly recommends that mung bean is an excellent nutritive legume, which modulates or prevents chronic degenerative diseases. …”
    Get full text
    Article
  17. 497

    Assessment of Molecular Imaging of Angiogenesis with Three-Dimensional Ultrasonography by Jason E. Streeter, Ryan C. Gessner, James Tsuruta, Steven Feingold, Paul A. Dayton

    Published 2011-11-01
    “…One of the limitations of preclinical US MI is that it lacks a comprehensive field of view. …”
    Get full text
    Article
  18. 498

    A combination of topical and systemic administration of brimonidine is neuroprotective in the murine optic nerve crush model. by Ruta Maciulaitiene, Giedrius Kalesnykas, Dainius Haroldas Pauza, Ingrida Januleviciene

    Published 2024-01-01
    “…<h4>Conclusions</h4>brimonidine eye drops supplemented with IP brimonidine injections improved RGC survival in a preclinical model of ONC.…”
    Get full text
    Article
  19. 499

    MCF-DTI: Multi-Scale Convolutional Local–Global Feature Fusion for Drug–Target Interaction Prediction by Jihong Wang, Ruijia He, Xiaodan Wang, Hongjian Li, Yulei Lu

    Published 2025-01-01
    “…Our case study demonstrates that our model effectively validated several known drug–target relationships in lung cancer and predicted the therapeutic potential of certain preclinical compounds in treating lung cancer. These findings contribute valuable insights for subsequent drug repurposing efforts and novel drug development.…”
    Get full text
    Article
  20. 500

    Mitotic Kinases and p53 Signaling by Geun-Hyoung Ha, Eun-Kyoung Yim Breuer

    Published 2012-01-01
    “…Because of their importance during mitosis and the relevance to cancer, mitotic kinase signaling has been extensively studied over the past few decades and, as a result, several mitotic kinase inhibitors have been developed. Despite promising preclinical results, targeting mitotic kinases for cancer therapy faces numerous challenges, including safety and patient selection issues. …”
    Get full text
    Article